PULSE BIOSCIENCES, INC. - Common Stock, par value $0.001 per share (PLSE) Institutional Ownership

13F Institutional Holders and Ownership History from Q2 2016 to Q4 2025

Type / Class: Equity / Common Stock, par value $0.001 per share
Symbol: PLSE on Nasdaq
Shares outstanding: 69,110,956
Price per share: $13.73
All holders as of 30 Sep 2025: Q3 2025
Total 13F shares: 5,847,549
Total reported value: $103,501,776
% of total 13F portfolios: 0%
Share change: -138,648
Value change: -$2,129,460
Number of holders: 82
Price from insider filings: $13.73

Reported Shares, Excluding Options vs Price

Reported Value, Excluding Options

Total Investors

Significant Owners of PULSE BIOSCIENCES, INC. - Common Stock, par value $0.001 per share (PLSE) based on Schedule 13D/G filings

Filer	Ownership	Change %	Holdings Value	Net Change	Nb Shares	Change %	Reporting Name	Report Period
DUGGAN ROBERT W	71%		$868,503,563		48,792,335		Robert W. Duggan	18 Dec 2024

As of 30 Sep 2025, 82 institutional investors reported holding 5,847,549 shares of PULSE BIOSCIENCES, INC. - Common Stock, par value $0.001 per share (PLSE). This represents 8.5% of the company’s total 69,110,956 outstanding shares.

Institutional Holders of PULSE BIOSCIENCES, INC. - Common Stock, par value $0.001 per share (PLSE) across Reporting Periods

Period	Reported Shares, Excl. Options	Value, Excl. Options	Value Change	Puts Notional Value	Calls Notional Value	Price (Median)	Investors
2025 Q4	133	$1,826	-$3,847			$13.73	2
2025 Q3	5,847,549	$103,501,776	-$2,129,460	$424,800	$520,380	$17.70	82
2025 Q2	5,984,466	$90,308,611	+$4,349,324	$507,024	$565,875	$15.09	85
2025 Q1	5,678,459	$91,367,899	-$5,798,556	$978,272	$1,224,449	$16.09	82
2024 Q4	5,966,828	$103,883,896	+$5,132,130	$905,320	$1,652,209	$17.41	71
2024 Q3	5,612,248	$98,415,057	+$11,001,269	$1,476,868	$2,429,290	$17.54	70
2024 Q2	4,831,221	$54,060,056	+$1,064,725	$1,076,478	$1,547,577	$11.19	56
2024 Q1	4,757,094	$41,427,267	+$2,924,385	$820,482	$2,079,077	$8.71	60
2023 Q4	4,336,775	$53,078,602	+$7,954,945	$629,136	$3,088,152	$12.24	49
2023 Q3	3,863,247	$15,567,515	+$685,290	$4,836	$756,834	$4.03	43
2023 Q2	3,635,816	$26,140,542	+$8,715,301	$0	$146,676	$7.19	45
2023 Q1	2,354,366	$7,910,339	-$336,779	$31,920	$774,144	$3.36	24
2022 Q4	2,458,733	$6,808,837	+$269,595	$364,809	$934,044	$2.77	26
2022 Q3	2,441,628	$5,607,741	-$1,322,192		$1,032,000	$2.30	26
2022 Q2	3,040,557	$4,651,369	-$3,031,805		$145,000	$1.53	35
2022 Q1	4,220,419	$20,520,031	-$3,953,330	$0	$0	$4.86	52
2021 Q4	4,070,521	$60,342,400	-$1,060,254	$536,000	$184,000	$14.81	47
2021 Q3	4,110,258	$88,855,150	+$21,153,376	$1,002,000	$2,091,000	$21.60	54
2021 Q2	3,148,929	$51,646,286	-$3,190,258	$0	$371,000	$16.40	53
2021 Q1	3,247,972	$76,908,396	+$4,719,921	$358,000	$590,000	$23.68	56
2020 Q4	3,048,395	$72,742,825	+$3,484,917	$291,000	$604,000	$23.86	53
2020 Q3	2,889,978	$34,070,968	-$377,193		$0	$11.79	44
2020 Q2	2,930,400	$30,649,075	+$7,653,890		$386,000	$10.46	49
2020 Q1	2,205,428	$15,786,060	-$304,466		$220,000	$7.16	44
2019 Q4	2,180,612	$29,238,376	+$1,117,358		$268,000	$13.41	43
2019 Q3	2,097,913	$32,389,638	+$1,065,691		$317,000	$15.44	45
2019 Q2	2,047,897	$31,828,447	+$3,200,073		$1,362,000	$13.20	40
2019 Q1	1,883,056	$33,121,736	+$2,312,351		$1,631,000	$17.59	41
2018 Q4	1,779,430	$20,389,240	+$71,355			$11.46	41
2018 Q3	1,754,783	$24,857,704	+$1,172,481	$0	$0	$14.19	44
2018 Q2	1,669,627	$25,260,353	+$2,517,725	$183,000	$502,000	$15.13	42
2018 Q1	1,513,882	$20,488,782	-$5,036,398	$267,000	$537,000	$13.53	44
2017 Q4	1,829,647	$43,174,696	+$7,591,789	$2,638,000	$637,000	$23.60	48
2017 Q3	1,520,354	$28,292,323	+$1,698,201	$2,816,000	$1,124,000	$18.60	43
2017 Q2	1,372,234	$47,377,976	+$32,589,071			$34.53	47
2017 Q1	435,988	$8,893,000	+$5,089,667			$20.39	29
2016 Q4	213,382	$1,373,000	-$169,372			$6.50	10
2016 Q3	241,681	$1,522,000	+$613,369			$6.31	12
2016 Q2	163,513	$734,000	+$734,000			$4.49	7